Rua Bioscience Limited — Regulatory Filings 2020

Oct 21, 2020

==> picture [97 x 47] intentionally omitted <==

LISTING AND QUOTATION NOTICE: NZX MAIN BOARD RUA BIOSCIENCE LIMITED (“RUA”) ORDINARY SHARES

Company: Rua Bioscience Limited Issuer Code: RUA ISIN: NZRUAE0004S1 Short Name: Rua Bioscience Registered Office: 1 Commerce Place, Awapuni Gisborne 4071 Website: www.ruabio.com Telephone Number: +64 (6) 390 6938 Financial Year End: 30 June Nature of Business: Rua is a New Zealand pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in Te Tairāwhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company to obtain a licence to cultivate cannabis for research purposes and the Company’s co-founder was actively involved in both the establishment of the key industry association and the development of the regulatory framework that is now in place to govern the sector. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain. Rua operates only in the medicinal part of the cannabis sector and has no plans to enter the recreational cannabis market in New Zealand or in any other country. Directors: Trevor Burt, (Chairman), Anna Stove, Martin Smith, Brett Gamble, and Panapa Ehau Details of Issue: The Offer consists of 40 million Shares Quoted Securities at 140,012,225 Completion of Offer: Minimum Application Amount: The minimum Application amount for eligible residents in the Gisborne constituency or shareholder of Waiapu Investment Limited is 200 Shares. 2,000 shares and thereafter in multiples of 100 shares under the Priority Offer Offer Price: $0.5 per share Tick Size: $0.01

NZX Limited, Level 1, NZX Centre, 11 Cable Street, PO Box 2959, Wellington 6140, New Zealand Tel +64 4 472 7599, www.nzx.com

==> picture [97 x 47] intentionally omitted <==

Lead Manager:

Co-Manager:

Auditors:

Solicitors:

Registrar:

Settlement Status:

Product Disclosure Statement Dated:

Priority Offer and Broker Firm Opens

Priority Offer Closes

Broker Firm Offer close

Allotment Date:

Earliest Mailing of Holder Notices:

Expected Commencement of Trading on the NZX Main Board:

Northington Partners Forsyth Barr Limited

Pricewaterhouse Coopers Lowndes Jordan Computershare Investor Services Limited NZCDC Settlement System 25 September 2020

Monday, 5 October 2020

Tuesday, 13 October 2020 Friday, 16 October 2020 Wednesday, 21 October 2020 Friday, 23 October 2020

Thursday, 22 October 2020

==> picture [131 x 63] intentionally omitted <==

Mark Peterson Chief Executive Officer NZX Limited

25 September 2020